Narrow Results

An Exclusive Interview with Executive Vice Dean of Duke—NUS Graduate Medical School Singapore, Dr Ranga Krishnan.

Developing the Family Physicians in Singapore.

Interview with Director of MDIS school of Life Sciences: Dr Andrew P. Lucy.

Novation, Cancer Therapeutics to Jointly Develop Cancer Therapies.

Mesoblast Announces Positive Results in Bone Marrow Transplant Trial.

Mingyuan Medicare Announces Collaboration on Major Infectious Diseases Detecting Platform.

DHL Launches first Life Science & Healthcare Competence Centre in Shanghai.

Abraxis Bioscience Launches ABRAXANE for Metastatic Breast Cancer.

GSK Enters Flu-Vax JV in China.

Biocon Launches Long Lasting Basal Insulin for Type 1 & Type 2 Diabetics.

Kemwell to build Biopharmaceutical Manufacturing Facility in India in Collaboration with Boehringer Ingelheim, Germany.

Hemispherx, Biken Expands Production Capacity for Swine Flu Vaccines.

D-SIMLAB Awarded S$500,000 Grant under SPRING Singapore's Technology.

GlaxoSmithKline Opens $600million Vaccine Plant.

Agilent Technologies Opens New Life Sciences Manufacturing Facility in Singapore.

Six Doctors Receive Clinician Scientist Awards.

Ultrasound-Mediated Gene Therapy - Philips and Glygenix Team Up.

Vietnam Healthcare - The Next Growth Frontier?

New Ultrasound System Could Lower Number of Biopsies.

Now growing at a rate of over 5% per annum, the $3 billion ‘alternative health therapies’ business is now positioned in the top ten growth industries in Australia. With poor regulation of both therapeutic goods and the unregistered therapists who promote them, cancer patients may well be putting their health at risk when they place their faith in many so-called ‘natural’ or ‘traditional’ treatments. With a focus on what complementary therapists refer to as ‘energy medicine’ and ‘nutritional medicine’, this chapter explores the risks and benefits of some of the more popular alternative health-care choices. While investigating their histories, it outlines what influences cancer patients to try these unproven therapies, and the conflict and contrast in information relating to the claims made for them and the conclusions of evidence-based research. Although there are a number of complementary therapies that are of benefit to some patients, both during and after their cancer treatments, ‘natural’ does not always equal ‘safe’, may be expensive and may even compromise their health. More patients now want a greater say in their choices of treatment, and selecting complementary therapies that may help is another of the many challenges faced in trying to make informed choices, as we navigate along our individual roads on our journeys to recovery.

This study explores the understanding of and the current status of adoption and use of the personally controlled electronic health record (PCEHR) system among Australian doctors and aims to identify concerns/issues associated with the PCEHR system and factors influencing their decision regarding adoption and use of the PCEHR system. A qualitative field study was undertaken, in which 10 doctors were interviewed. The outcomes of this study lay good foundation for subsequent studies.